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A systematic review of spinal cord injury and
cerebrospinal fluid drainage after thoracic aortic
endografting
Chee S. Wong, MRCSI,a Donagh Healy, MRCSI,a Catriona Canning, MD, MRCSI,a
J. Calvin Coffey, PhD, FRCS,a Jonathan R. Boyle, MD, FRCS,b and
Stewart R. Walsh, MCh, FRCS,a Limerick, Ireland; and Cambridge, United Kingdom
Background: The use of thoracic endovascular aneurysm repair (TEVAR) is increasing. Similar to open repair, TEVAR
carries a risk of spinal cord ischemia (SCI). We undertook a systematic review to determine whether preoperative
cerebrospinal fluid (CSF) drainage reduces SCI.
Methods: PubMed, the Cochrane Library, and conference abstracts were searched using the keywords thoracic endovascular
aortic repair, cerebrospinal fluid, spinal cord ischaemia, TEVAR, and aneurysm. Studies reporting SCI rates and CSF drain
rates for TEVAR patients were eligible for inclusion. SCI rates across studies were pooled using random-effects modeling.
Study quality was evaluated using the Downs and Black score.
Results: Study quality was generally poor to moderate (median Downs and Black score, 9). The systematic review
identified 46 eligible studies comprising 4936 patients; overall, SCI affected 3.89% (95% confidence interval, 2.95.05%-
4.95%). Series reporting routine prophylactic drain placement or no prophylactic drain placement reported pooled SCI
rates of 3.2% and 3.47%, respectively. The pooled SCI rate from 24 series stating that prophylactic drainage was used
selectively was 5.6%.
Conclusions: Spinal chord injury is uncommon after TEVAR. The role of prophylactic CSF drainage is difficult to establish
from the available literature. High-quality studies are required to determine the role of prophylactic CSF drainage in
TEVAR. (J Vasc Surg 2012;56:1438-47.)
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bThoracic endovascular aneurysm repair (TEVAR) has
emerged as an alternative to traditional open repair.1 Al-
though morbidity and mortality rates are lower with
TEVAR, there remains a risk of neurologic complications,
including stroke and spinal cord ischemia (SCI).2 The
precise pathophysiology of SCI after TEVAR is unclear but
is probably multifactorial. Contributing factors may in-
clude occlusion of multiple intercostal vessels by long-
segment stenting, occlusion of the left subclavian or hypo-
gastric arteries, perioperative hypotension resulting in
watershed ischemia in the midthoracic spinal cord, and
previous abdominal aortic surgery.2 SCI may be amelio-
rated through the use of cerebrospinal fluid (CSF) drainage
(CSFD). Experimental studies3-6 showed that CSF pres-
sure reductions led to an increase in spinal cord perfusion
pressure.
At present, there is little consensus regarding the role of
CSFD in TEVAR. Some units routinely use prophylactic
CSFD in all patients undergoing TEVAR, whereas others
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1438ely on selective or no routine prophylactic CSFD, with
escue CSFD as required. We undertook a systematic re-
iewwith two aims: to establish the overall incidence of SCI
fter TEVAR in published series and, if possible, to deter-
ine the effect of routine prophylactic CSFD on SCI rates
mong patients undergoing TEVAR. However, we recog-
ized from the outset that clinical heterogeneity within and
etween reported TEVAR series, combined with a lack of
ata regarding SCI risk factors within individual study
ohorts, would limit the ability to draw robust conclusions
egarding the role of prophylactic CSFD. In particular, it
as unlikely that the generation of pooled odds ratios
omparing the three possible strategies of no drain, routine
rain, or selective drain placement would be appropriate.
ETHODS
The systematic review was conducted in accordance
ith the Preferred Reporting Items for Systematic Reviews
nd Meta-Analyses (PRISMA) guidelines.7 The PubMed
nd Medline databases were searched for series from 1991
o 2011 reporting outcomes after thoracic aortic en-
ografting. The following search terms were used: thoracic
ndovascular aortic repair, cerebrospinal fluid drainage,
pinal cord ischaemia, thoracic, and aneurysm. These terms
ere searched using Boolean operators in five separate
locks:
● Block 1: thoracic aneurysms and spinal and aortic
repair
● Block 2: thoracic and aneurysms and spinal
● Block 3: thoracic endovascular and cerebrospinal fluid
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Volume 56, Number 5 Wong et al 1439● Block 4: thoracic and endovascular and spinal and
paraplegia
● Block 5: thoracic and aneurysms and paraplegia
No language restrictions were used. Reference lists
from articles obtained through the electronic search were
scrutinized for further relevant publications. A manual
search was conducted for relevant abstracts presented at the
Vascular Society of Great Britain and Ireland, the European
Society of Vascular Surgery, and the Society for Vascular
Surgery (2000 to 2011). One author (C.S.W.) screened
potentially eligible abstracts identified by the systematic
review.
Articles were eligible for inclusion if the following
criteria were satisfied: case series, case-control study, cohort
study, or randomized clinical trial that reported SCI rates
(permanent or transient, early or delayed, paraplegia or
paraparesis) after elective or emergency TEVAR, including
hybrid procedures. Any patient reported to develop perma-
nent or transient or early or delayed paralysis or paraparesis
was deemed to have sustained SCI for the purpose of the
review.
Only prophylactic CSFD was considered. Thus, data
Table I. Downs and Black checklist
Reporting (10 items)
● Is the hypothesis/aim/objective of the study clearly described
● Are the main outcomes to be measured clearly described in th
● Are the characteristics of the patients included in the study cle
● Are the interventions of interest clearly described?
● Are the distributions of principal confounders in each group o
● Are the main findings of the study clearly described?
● Does the study provide estimates of the random variability in
● Have all important adverse events that may be a consequence
● Have the characteristics of patients lost to follow-up been des
● Have actual probability values been reported (eg, P  .035 ra
probability value is .001?
External validity (3 items)
● Were the subjects asked to participate in the study representat
● Were those subjects who were prepared to participate represen
● Were the staff, places, and facilities where the patients were tr
Internal validity (bias) (7 items)
● Was an attempt made to blind study subjects to the interventi
● Was an attempt made to blind those measuring the main outc
● If any of the results of the study were based on “data dredgin
● In trials and cohort studies, do the analyses adjust for differen
time period between the intervention and outcome the same
● Were the statistical tests used to assess the main outcomes app
● Was compliance with the intervention/s reliable?
● Were the main outcome measures used accurate (valid and rel
Internal validity (confounding) (6 items)
● Were the patients in different intervention groups (trials and c
recruited from the same population?
● Were study subjects in different intervention groups (trials an
recruited over the same period of time?
● Were study subjects randomized to intervention groups?
● Was the randomized intervention assignment concealed from
and irrevocable?
● Was there adequate adjustment for confounding in the analys
● Were losses of patients to follow-up taken into account?
Power (1 item)
● Did the study have sufficient power to detect a clinically impo
chance is less than 5%?regarding prophylactic CSFD were extracted for three lroups of studies: those reporting that no form of pro-
hylactic CSFD was used, those reporting a policy of
outine CSFD placement, and those reporting a policy of
elective prophylactic CSFD, whereby drains were placed
reoperatively in high-risk patients. Patients who re-
eived drains for the treatment of SCI (ie, rescue drains)
ere not included in the drain group totals from the
elective series. We excluded series reporting SCI rates
fter open thoracic or thoracoabdominal aneurysm re-
air and studies reporting the results of experiments in
nimal models.
In addition to publishing their own center’s results, a
umber of units also contributed patients to multicenter
eports. Consequently, the analysis was restricted to single-
enter series to avoid double-counting patients reported by
he responsible clinical center and as part of a multicenter
ollaboration.
Data for SCI rates were extracted from the eligible
tudies and entered into a computerized spreadsheet.
rophylactic CSFD policy (routine, never, or selective)
as recorded for each study. When studies reported SCI
ates according to placement or otherwise of a prophy-
oduction or methods section?
escribed?
jects to be compared clearly described?
ata for the main outcomes?
e intervention been reported?
?
han P  .05) for the main outcomes, except where the
f the entire population from which they were recruited?
e of the entire population from which they were recruited?
, representative of the treatment the majority of patients receive?
ey have received?
of the intervention?
as this made clear?
ths of follow-up of patients, or in case-control studies, is the
ses and controls?
ate?
?
t studies) or were the cases and controls (case-control studies)
ort studies) or were the cases and controls (case-control studies)
patients and health care staff until recruitment was complete
m which the main findings were drawn?
effect where the probability value for a difference being due to?
e intr
arly d
f sub
the d
of th
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rtantactic drain, SCI rates for both subgroups were extracted.
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pooled rate of SCI after thoracic endovascular interven-
tions.
Heterogeneity was assessed by means of the Cochran
Q test, a null hypothesis test in which values at P  .05
indicate the presence of significant heterogeneity. Het-
erogeneity, also referred to as inconsistency, is a measure
of the degree of noncombinability of studies included in
a meta-analysis and is calculated as the weighted sum of
squared differences between individual study effect sizes
and the overall pooled effect estimate. The greater the
differences, the more likely it is that significant clinical
differences exist among the patient cohorts studied or
that significant methodologic differences exist among
the individual studies.
Bias was assessed by visual inspection of a funnel plot.
Funnel plots exploit the observation that, in the absence
of small sample bias, the effect size estimates for small
studies should vary to a much greater degree than those
from larger studies due to natural random variation. There-
fore, plots of sample size against effect size variation should
result in funnel-shaped plots. Asymmetry in such plots
implies the existence of bias, which is usually publication
bias due to nonpublication of small studies with negative
results.
The statistical analyses were undertaken using Stats-
direct 2.7.8 software (Statsdirect Ltd, Altrincham, UK).
The 5% level was taken as significant throughout. Study
quality was assessed by means of the Downs and Black
score,8 which uses 27 criteria to evaluate the quality of
nonrandomized studies with respect to five quality do-
mains (reporting, external validity, bias, confounding,
and power). The scoring was performed by answering all
 
 
Records screened by tle (n = 15,678) 
Abstracts screened according to inclusion 
/ exclusion criteria (n = 242) 
63 eligible arcles included
Full-text arcles screened for inclusion 
(n=97) 
Records idenﬁed 
through database 
searching  
(n = 15,528)  
Addional records 
idenﬁed through 
other sources    
(n = 150)  
46 included studies  
Fig 1. Preferred Reporting Items for Systematic Revie
systematic review.uestions in the checklist, which were scored 0 to 2.
ossible total scores range from 0 (poor quality) to 31
high quality). Full details of the checklist are provided in
able I.
ESULTS
The systematic review identified 15,528 citations, of
hich 46 were included in the final pooled analysis (Fig 1).
o randomized trials to date have evaluated the role of
rophylactic CSFD in TEVAR. Details of the 46 eligible
eries are summarized in Table II. Although all 46 reported
ostoperative SCI rates, only 26 studies documented a clear
olicy regarding prophylactic CSFD (ie, routine drainage,
o drainage, or selective drainage). The eligible studies
enerally comprised heterogenous cohorts of patients un-
ergoing elective or emergency treatment of a wide range
f thoracic aortic pathologies, including dissection, degen-
rative aneurysm, penetrating aortic ulcer, and traumatic
ransection, as well as patients undergoing complex hybrid
nd fenestrated repairs.
Quality evaluation. All 46 series were evaluated using
he Downs and Black template. The median score was 9
range, 5-12), indicating that the general quality of the
ncluded studies was poor to moderate. The reporting
omain, which evaluates factors such as clear statement of
ims, reporting of baseline characteristics, outcome defini-
ions and confounding, had a median score of 4 (range,
-7) of a possible 11.
Overall SCI rate. Spinal cord injury was reported by all
6 eligible studies.9-54 SCI occurred in 206 patients, yield-
ng a pooled incidence rate of 3.88% (95% confidence
nterval [CI], 2.95%-4.95%). There was evidence of signif-
cant heterogeneity (Cochran Q  129.08; P  .0001).
Excluded by tle (n=15,436)
Excluded by abstract screening (n= 145) 
Excluded aer scruny of full arcle (n = 26) 
Exclude overlapping results (n = 17) 
d Meta-Analyses (PRISMA) diagram summarizes thews an
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(Fig 2), and there was statistical evidence of bias (Egger 
1.40; P  .001).
SCI after routine prophylactic drainage. Three
studies (404 patients)34,44,48 reported SCI rates after rou-
tine placement of a prophylactic spinal drain. SCI occurred
in 12 patients. The pooled rate was 3.2% (95% CI, 1.7%-
5.1%). There was no evidence of heterogeneity (Cochran
Q  1.58; P  .45). There were insufficient studies to
reliably evaluate bias.
SCI without routine prophylactic drainage. Eight
studies (451 patients) stated14,25,27,28,32,38,43,53 that no
prophylactic drains were placed. SCI occurred in 18 pa-
tients. The pooled SCI rate was 3.47% (95% CI, 1.98%-
5.37%). There was no evidence of heterogeneity (Cochran
Q  8.34; P  .303) or bias (Egger  1.02; P  .18).
SCI with selective prophylactic drainage. A policy of
selective prophylactic drainage was used in 15 studies (2569
patients).15,29,30,33,35,39-42,45,46,49,50,52,54 All studies re-
ported prophylactic drain placement in patients deemed at
high risk for SCI, although definitions of high risk varied.
The pooled rate of SCI in this group was 5.60% (95% CI,
4.00%-7.40%). There was evidence of significant heteroge-
neity (Cochran Q 44.43; P .001). The funnel plot was
skewed (Fig 3), and there was evidence of bias (Egger 
1.76; P  .06). Among the 15 selective series, six studies
(1168 patients)33,39,46,49,50,54 reported a breakdown of
SCI rates with respect to prophylactic drain placement. SCI
occurred in 29 of 424 patients (6.8%) with a prophylactic
drain vs 53 of 764 patients (6.9%) without a drain.
Random-effects modeling showed there was no significant
difference in SCI risk between patients who did and did not
have a prophylactic CSFD placed in the subgroup reporting
this outcome (pooled odds ratio, 0.67; 95% CI, 0.22-2.08;
P  .49). There was no evidence of heterogeneity (Coch-
ran Q  8.66; P  .07).
DISCUSSION
Spinal cord injury is a well-recognized complication of
open and endovascular thoracic aortic interventions. SCI
may complicate up to 20% of open thoracic aortic proce-
dures. Numerous strategies to reduce SCI risk have been
devised, including cooling, CSFD, and intercostal vessel
reimplantation. The use of prophylactic CSFD in open
surgery has been the subject of two meta-analyses.55,56
Although based on small patient samples, both concluded
that prophylactic drainage significantly reduces the risk of
perioperative paraplegia or paraparesis. To date, three ran-
domized controlled trials57-59 have examined the benefits
of lumbar CSFD in open thoracoabdominal aortic aneu-
rysm repairs. The largest and most recent randomized
controlled trial, by Coselli et al,59 reported that prophylac-
tic CSFD significantly reduced the risk of paraplegia (13%
vs 2.6%; P  .03). The role of prophylactic CSFD in
endovascular procedures is more contentious. Level 1 evi-
dence that supports the role of CSFD is still lacking in the
era of endovascular repairs. eSCI risk after TEVAR is generally lower, although
ndividual case series report rates of between 0% and 20%.52
erioperative SCI after thoracic aortic interventions is as-
ociated with impaired medium-term survival.40 It also
epresents a potentially avoidable burden on health care
conomies because this complication renders many patients
ependent for most activities of daily living. A recent large-
cale comparison of patients undergoing open and endo-
ascular thoracic aortic procedures in the United States
oted that the TEVAR patients had greater comorbidities
han the open repair patients, rendering them at increased
isk of complications.60 TEVAR is now an established
omponent in thoracic aortic therapy. Increasingly, atten-
ion must focus on methods to reduce complications after
EVAR.
The current systematic review establishes the overall
ooled incidence of SCI after TEVAR. Random-effects
odeling yielded a pooled SCI rate of 3.88% (95% CI,
.95%-4.85%). Two major caveats should be noted:
irst, significant statistical heterogeneity exists among the
included studies. This is not surprising, because the
sample mixes emergency and elective patients undergo-
ing a range of thoracic aortic procedures covering var-
ious aortic lengths to treat a range of pathologic pro-
cesses. Attempting to refine the sample, for example, by
only focusing on single pathologies or elective cases,
would have been extremely difficult because most au-
thors only report pooled results from very mixed co-
horts.
econd, the funnel plot for the overall SCI rate is asymmet-
ric (Fig 2). No studies are left in the bottom left corner
of the plot, where one would expect a number of small
series reporting a high SCI rate. This appearance of the
plot, together with the statistically significant Egger
test for bias, is very suggestive of publication bias. Thus,
the pooled SCI rate of 3.7% produced in our meta-
analysis may underestimate the true risk of SCI after
TEVAR.
The utility of prophylactic CFSD is difficult to establish
rom the available literature. Analysis of the three studies
eporting routine drain placement produced a pooled SCI
ate of 3.2% compared with 3.47% among the eight studies
n which no drains were placed. The 15 series reporting a
elective policy yielded a pooled rate of 5.6%, higher than
ither of the other two groups. In the subgroup in which
CI rates were reported according to drain placement,
rophylactic drain use did not appear to reduce SCI
pooled odds ratio, 0.22-2.08).
We point out, however, that in all of these series,
rophylactic CSFDs were placed only in patients deemed
t high risk of perioperative SCI. Thus, there is an
nherent bias in the analysis, in that the CSFD group was
t increased risk of SCI. Given this context, it could be
rgued that the similar SCI rates achieved in the high-
isk and low-risk groups in these studies represent suc-
essful use of CSFD. However, the risk of SCI is influ-
nced by a host of factors, among them hypogastric
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First author Year No. Study type Aortic pathologies included
Ehrlich9 1998 10 Retrospective True aneurysms, dissection
Ishimaru10 1998 16 Retrospective Atherosclerotic/degenerative, aortic dissection,
pseudoaneurysm
Mitchell11 1999 103 Retrospective Atherosclerotic/degenerative, aortic dissection, trauma
Greenberg12 2000 25 Retrospective True aortic aneurysmal (excluded mycotic and acute
dissection)
Won13 2001 23 Retrospective Aortic aneurysms, aortic dissection
Criado14 2002 47 Retrospective Aortic aneurysms, aortic dissection
Lepore15 2002 43 Retrospective Aortic dissections, aortic aneurysms, ruptures, mycotic
aneurysms, post-traumatic pseudoaneurysms
Usui16 2002 24 Retrospective True aneurysms, chronic dissection, penetrating aortic
ulcer
Bergeron17 2003 38 Retrospective Aortic aneurysms, aortic dissection, aortic rupture
Orend18 2003 74 Retrospective Atherosclerotic aneurysm, posttraumatic aneurysm,
chronic type B dissection
Chabbert19 2003 47 Prospective Traumatic thoracic aortic ruptures, aneurysms, false
aneurysms, penetrating ulcers, dissections
Krohg-Sorenson20 2003 20 Retrospective Degenerative, mycotic, pseudoaneurysm, aortic
dissection, penetrating ulcer, aortitis
Lambrechts21 2003 26 Retrospective Traumatic aortic rupture, type B dissection, descending
thoracic aortic aneurysm
Matravers22 2003 24 Retrospective Descending thoracic aorta, type B dissection,
penetrating ulcers, traumatic pseudoaneurysm
Lamme23 2003 21 Retrospective True aneurysms, false aneurysms, traumatic rupture,
mycotic aneurysms, ruptured aneurysm
Czerny24 2004 54 Retrospective Atherosclerotic aneurysms (excluded type B aortic
dissections, perforating ulcers, traumatic dissections)
Neuhauser25 2004 31 Retrospective Atherosclerotic descending TAAs (excluded traumatic
rupture, type B dissection)
Bortone26 2004 132 Retrospective True aneurysms, post-traumatic lesions, type B
dissections
Brandt27 2004 22 Retrospective True aneurysms, dissection
Hansen28 2004 59 Retrospective TAA, thoracic dissection, penetrating ulcer
Chiesa29 2005 103 Prospective True aneurysm, chronic dissection, aortic ulcer
Baril30 2006 125 Retrospective Previous or concomitant AAA
Marcheix31 2006 45 Prospective Atherosclerotic aneurysm (excluded aortic dissections,
penetrating ulcers, and traumatic)
Ricco32 2006 166 Retrospective Degenerative aortic aneurysm, type B chronic
dissecting aneurysm, traumatic pseudoaneurysm,
aortic ulcer, septic aortic aneurysm
Iyer33 2006 70 Retrospective True aneurysms, dissection, intramural hematoma,
traumatic aortic transection, aortoesophageal fistula
Morales34 2007 186 Retrospective Degenerative, dissection, mycotic, transection,
coarctation, vasculitis
Sandroussi35 2007 65 Retrospective Degenerative aneurysm, type B dissection, traumatic
transection, penetrating ulcer
Khoynezhad36 2007 153 Retrospective Descending thoracic aortic aneurysm, type B aortic
dissection type, aortic transection, penetrating aortic
ulcer
Kawaharada37 2007 149 Retrospective TAA
Amabile38 2008 67 Retrospective Degenerative aneurysm, type B dissection, traumatic
rupture, penetrating aortic ulcer, anastomotic false
aneurysm, mycotic aneurysm, embolic aortic lesion
Hnath39 2008 121 Prospective TAA, penetrating ulcers, pseudoaneurysms, traumatic
aortic transactions
Conrad40 2008 105 Prospective TAA
Greenberg41 2008 352 Retrospective TAA and TAAA (excluded aortic rupture or acute
dissection)
Qu42 2008 87 Retrospective TAA, aortic dissection
Pearce43 2008 15 Retrospective Type B thoracic aortic dissection
Siegenthaler44 2008 21 Retrospective TAAA
Chang45 2008 37 Retrospective TAAA
Preventza46 2009 346 Prospective True aneurysm, type B aortic dissection, penetrating
aortic ulcer
47Kische 2009 180 Retrospective Aortic dissection
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Prophylactic
CSFD policy (No.) Other neuroprotection used
SCI
No. (%)
Downs and
Black score
Not reported None 0 (0.00) 8
Not reported Evoked spinal cord potential
monitoring
0 (0.00) 6
Not reported None 3 (2.91) 9
Not reported None 3 (12.00) 12
Not reported None 0 (0.00) 9
Did not use drain None 0 (0.00) 5
Selective (?) None 3 (6.98) 9
Not reported None 3 (12.50) 6
Not reported None 0 (0.00) 6
Not reported None 2 (2.70) 6
Not reported None 3 (6.38) 8
Not reported None 0 (0.00) 8
Not reported None 0 (0.00) 9
Not reported None 0 (0.00) 8
Not reported None 1 (4.76) 9
Not reported None 0 (0.00) 8
Did not use drain None 2 (6.45) 9
Not reported None 0 (0.00) 9
Did not use drain Local hypothermia 1 (4.55) 9
Did not use drain None 1 (1.69) 11
Selective (7) Maintain MAP 4 (3.88) 10
Selective (27) None 5 (4.00) 6
Not reported None 2 (4.44) 9
Did not use drain None 6 (3.61) 9
Selective (49) None 0 (0.00) 12
Routine None 7 (3.76) 6
Selective (?) None 4 (6.15) 8
Not reported None 8 (5.23) 10
Not reported None 3 (2.01) 10
Did not use drain None 5 (7.46) 9
Selective (56) Vasopressor to maintain
MAP
5 (4.13) 10
Selective (27) Epidural cooling 7 (6.67) 10
Selective (?) None 15 (4.26) 12
Selective (61) None 3 (3.45) 11
Did not use drain None 2 (13.33) 8
Routine SSEP 1 (4.76) 9
Selective (31) Maintain MAP 7 (18.92) 9Selective (4) LSA revascularization 14 (4.05) 8
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November 20121444 Wong et alartery patency, intercostal vessel occlusion, length of
thoracic aorta stented, and previous infrarenal aneurysm
repair. The current data are insufficient to allow any
corrections for these confounding factors, thus limiting
the conclusions that can be drawn from the literature
regarding prophylactic CSFD.
CSFD placement is not without complications, which
include spinal canal hematomas, neurologic injury, and
postdrainage headache, which is the most common re-
ported complication.61,62 The included studies did not
report a systematic evaluation of complications arising from
prophylactic drains. The benefit of any intervention must
be weighed against the risks. Currently, there are insuffi-
cient data to allow meaningful evaluation of the risks vs the
Bias
-0.2 -0.1
0.08
0.06
0.04
0.02
0.00
Standard error
Fig 2. Funnel plot shows the spinal cord injury rat
Table II. Continued.
First author Year No. Study t
Chaikof48 2009 197 Retrospe
Drinkwater49 2010 231 Retrospe
Matsuda50 2010 60 Retrospe
Geisbüsch51 2010 236 Retrospe
Ullery52 2010 424 Retrospe
Mitchell53 2010 44 Retrospe
Lee54 2010 400 Retrospe
CSFD, Cerebrospinal fluid drainage; LSA, left subclavian artery; MAP, m
potential; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aorticbenefits of prophylactic CSFDs in TEVAR. gONCLUSIONS
Overall, the available literature regarding prophylactic
SFD in TEVAR patients is of only moderate quality, as
ndicated by the Downs and Black scores (Table I). Data
egarding complications are lacking. The influence of con-
ounding factors is impossible to evaluate. Level 1 evidence
rom open surgery suggests that prophylactic CSFD is of
enefit, but the risks and benefits cannot be accurately
stimated from the current available TEVAR literature. An
dequately powered clinical trial, in which patients are
tratified for pre-existing risk factors, is likely to be the only
eans by which the role of prophylactic CSFD can be
scertained with reasonable confidence in patients under-
ssment plot
0.0 0.1 0.2
Proportion
r thoracic endovascular aneurysm repair (TEVAR).
Aortic pathologies included
Degenerative aneurysms, type B aortic dissection,
mycotic aneurysms, traumatic disruptions, intramural
hematoma, pseudoaneurysm
Degenerative atherosclerotic aneurysms, type B
dissections, penetrating atherosclerotic ulcers,
pseudoaneurysms, aortic transections
TAA and TAAA
Ruptured TAA
Degenerative aneurysm, dissection
Traumatic aortic disruption, ruptured descending
thoracic aneurysm, complicated type B dissection
True aneurysms, dissections, penetrating ulcers,
traumatic transections
rterial pressure; SCI, spinal cord ischemia; SSEP, somatosensory-evoked
ysm. asseype
ctive
ctive
ctive
ctive
ctive
ctive
ctive
ean aoing TEVAR.
ates i
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